Stefanik cosponsors ALS Act

WASHINGTON, D.C. | U.S. Rep. Elise Stefanik (R) has cosponsored the Accelerating Access to Critical Therapies for ALS Act. The bipartisan legislation supports funding for ALS research and treatments with a grant program to fund access to investigative treatments. It also builds on the FDA's role in approving treatments and accelerating a path toward improved treatments. The legislation would establish a new FDA grant program called the Rare Neurodegenerative Disease Grants program. Stefanik also sent a letter requesting support for the ALS Research Program and ALS Registry within the Department of Defense during this year's appropriations process. "ALS is a disease that unfortunately affects many families in the North Country and throughout the United States," Stefanik said in a statement recently announcing the measure. "This important bill supports investigational ALS treatments and initiates more collaboration between public-private partners to allow federal agencies, patients, families, clinicians, and drug manufacturers to create a more successful path for drug discovery. It is crucial that we continue to fund research to find treatments and a cure for this devastating disease, and I look forward to furthering this effort along with my House colleagues."

Signup for our newsletter

Stefanik cosponsors ALS Act

COMPANY

CUSTOMER SUPPORT

SUBMISSION FORMS

BEYOND THE NEWS